Subsequently, the enzyme-labeled RSV-specific antibodies are added ... changes the appearance of the silicon wafer. While RADT test kit performance profiles are relatively similar, particular ...

Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This CE-IVD marked multiplex PCR test is specifically designed to detect and ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

Healthy adults and older children don’t usually need RSV testing, though some at-home kits test for Covid-19 ... with the injectable RSV monoclonal antibody, nirsevimab, between March and ...

This week, The FDA accepted Merck & Co.’s biologics license application for the monoclonal antibody clesrovimab, which works differently from a vaccine but also provides protection against RSV.

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Persons with self-reported immunocompromising conditions were enrolled in the antibody response trial. HealthDay News — For immunocompromised individuals, antibody response to respiratory ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

Inhalon’s RSV candidate is one of several potential therapies being developed based on the company’s inhaled antibody technology for acute respiratory infections. The inhaled route of ...

There are currently no approved treatments for the underlying RSV infection," said John Whelan, president and chief executive officer of Inhalon Biopharma. "Inhalon’s inhaled antibody treatment ...